Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this session, "An Eagle's View - Evidence-based discussion on Iron Deficiency Anemia." This discussion will provide a high-level, evidence-based overview of Iron Deficiency Anemia (IDA), the most common nutritional deficiency worldwide. Despite its prevalence, IDA is often underdiagnosed and undertreated, leading to significant health consequences. This session will offer a fresh perspective on the latest clinical data, moving beyond traditional approaches to focus on effective and patient-centered management strategies.
The discussion will explore the evidence supporting different therapeutic options, including oral iron supplementation and intravenous iron infusions. We'll delve into the specific patient populations that benefit most from each approach, such as those with intolerance to oral supplements, pregnant women, or patients with chronic conditions. Recent research has highlighted the improved safety and efficacy of modern intravenous iron formulations, making them a more viable and often preferred option for rapid iron replenishment and symptom relief. We will also address the challenges in diagnosis, particularly when inflammatory markers are elevated.
Therefore, get an overall knowledge of the evidence-based best practices in the diagnosis and treatment of iron deficiency anemia. Listen to the webinar, absorb the shared knowledge, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation